Old Web
English
Sign In
Acemap
>
Paper
>
Cross the Undruggable Barrier, the Development of SHP2 Inhibitors: From Catalytic Site Inhibitors to Allosteric Inhibitors
Cross the Undruggable Barrier, the Development of SHP2 Inhibitors: From Catalytic Site Inhibitors to Allosteric Inhibitors
2021
Yu Guo
Yaping Xu
Xiaowu Dong
Jianjun Zhang
Keywords:
Cancer
Allosteric regulation
Protein tyrosine phosphatase
Chemistry
Catalysis
Biochemistry
Correction
Source
Cite
Save
Machine Reading By IdeaReader
110
References
0
Citations
NaN
KQI
[]